Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Remacemide for Drug-resistant Localization Related Epilepsy: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434228/2/. Accessed 16 May 2024.
Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/2/. Accessed May 16, 2024.
Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/2/
Remacemide for Drug-resistant Localization Related Epilepsy: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/2/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review
ID - 434228
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/2/
DB - Evidence Central
DP - Unbound Medicine
ER -